{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:00:33Z","timestamp":1793530833553,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jacc.2024.03.423","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:45:30Z","timestamp":1717425930000},"page":"2262-2273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Excess Apolipoprotein B and Cardiovascular Risk in Women and Men"],"prefix":"10.1016","volume":"83","author":[{"given":"Camilla Ditlev Lindhardt","family":"Johannesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-7223","authenticated-orcid":false,"given":"Anne","family":"Langsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge Gr\u00f8nne","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B\u00f8dtker","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10226","key":"10.1016\/j.jacc.2024.03.423_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.jacc.2024.03.423_bib2","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2024.03.423_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"34","key":"10.1016\/j.jacc.2024.03.423_bib4","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacc.2024.03.423_bib5","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2024.03.423_bib6","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2024.03.423_bib7","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2024.03.423_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.423_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.423_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","article-title":"Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population","volume":"61","author":"Varbo","year":"2015","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.jacc.2024.03.423_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.423_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.ATV.9.2.176","article-title":"Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences","volume":"9","author":"Nordestgaard","year":"1989","journal-title":"Arteriosclerosis"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.423_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"Otvos","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacc.2024.03.423_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jacl.2023.05.093","article-title":"Is hypertriglyceridemia a reliable indicator of cholesterol-depleted apoB particles?","volume":"17","author":"De Marco","year":"2023","journal-title":"J\u00a0Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacc.2024.03.423_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2024.03.423_bib16","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"issue":"2-3","key":"10.1016\/j.jacc.2024.03.423_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0021-9150(91)90050-D","article-title":"Effect of moderate hypertriglyceridemia on the relation of plasma total and LDL apo B levels","volume":"89","author":"Sniderman","year":"1991","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.423_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/ATVBAHA.114.304349","article-title":"Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart\u00a0Association\/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Steffen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.423_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.ATV.0000255580.73689.8e","article-title":"Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study","volume":"27","author":"Benn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.jacc.2024.03.423_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","article-title":"Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease","volume":"140","author":"Welsh","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacc.2024.03.423_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2024.03.423_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOL.0000000000000318","article-title":"Diabetic dyslipidaemia","volume":"27","author":"Soran","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"10.1016\/j.jacc.2024.03.423_bib23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem"},{"issue":"25","key":"10.1016\/j.jacc.2024.03.423_bib24","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.423_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2004.02.013","volume":"173","author":"De Backer","year":"2004","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.jacc.2024.03.423_bib26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacc.2024.03.423_bib27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/2047487315569411","article-title":"Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C","volume":"22","author":"Pencina","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2024.03.423_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOL.0000000000000127","article-title":"Discordance analysis and the Gordian knot of LDL and non-HDL cholesterol versus apoB","volume":"25","author":"Sniderman","year":"2014","journal-title":"Curr Opin Lipidol"},{"issue":"23","key":"10.1016\/j.jacc.2024.03.423_bib29","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.423_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.423_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamacardio.2021.5083","article-title":"Association of Apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis: distinguishing between particle concentration, type, and content","volume":"7","author":"Marston","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2024.03.423_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1194\/jlr.R082271","article-title":"Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding","volume":"59","author":"Sniderman","year":"2018","journal-title":"J\u00a0Lipid Res"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972406889X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972406889X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T21:36:45Z","timestamp":1764884205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972406889X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S073510972406889X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.03.423","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excess Apolipoprotein B and Cardiovascular Risk in Women and Men","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.03.423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}